Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Homologous Recombination Deficiency Status and Resistance to PARP Inhibitors in Chinese Epithelial Ovarian Cancer Patients

NCT05310370 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT05310370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05310370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Homologous Recombination Deficiency Status and Resistance to PARP Inhibitors in Chinese Epithelial Ovarian Cancer Patients
Lead sponsor
Lei Li
Phase
Observational
Overall status
Unknown status
Start date
March 26, 2022
Completion date
March 26, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistance, epithelial ovarian cancer, homologous recombination deficiency, homologous recombination repair gene mutation, overall survival, poly(adp-ribose) polymerase inhibitor, progression-free survival